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Abstract 
Background – hearing voices can be a common and distressing experience. Psychological 
treatment in the form of Cognitive Behaviour Therapy for Psychosis (CBTp) is effective, but 
is rarely available to patients. The barriers to increasing access include a lack of time for 
clinicians to deliver therapy. Emerging evidence is suggesting that CBTp delivered in brief 
forms can be effective and offer one solution to increasing access. 
Aims – we adapted an existing form of CBTp, Coping Strategy Enhancement (CSE), to focus 
specifically on distressing voices in a brief format. This intervention was evaluated within an 
uncontrolled study conducted in routine clinical practice.    
Methods - This was a service evaluation comparing pre-post outcomes in patients who had 
completed CSE over four sessions within a specialist outpatient service within NHS Mental 
Health Services. The primary outcome was the Distress scale of the Psychotic Symptoms 
Rating Scale – Auditory Hallucinations (PSYRATS-AH). 
Results – data were available from 101 patients who had completed therapy. A reduction 
approaching clinical importance was found on the PSYRATS distress scale post-therapy 
when compared to the baseline. 
Conclusions – the findings from this study suggest that CSE, as a focussed and brief form of 
CBTp can be effective in the treatment of distressing voices within routine clinical practice. 
Within the context of the limitations of this study, brief CSE may best be viewed as the 
beginning of a therapeutic conversation and a low-intensity intervention in a stepped 
approach to the treatment of distressing voices.  
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Introduction 
The experience of hearing voices is reported by 70% of patients with a diagnosis of 
Schizophrenia Spectrum Disorder (Thomas et al., 2007) and is also common in other 
psychiatric diagnoses, e.g. Borderline Personality Disorder (Sommer et al., 2012). This 
experience can have a devastating effect on patients’ lives due to high levels of distress 
(Birchwood & Chadwick, 1997), depression (Birchwood et al., 2004) and an increased risk of 
suicide (Kjelby et al., 2015).
Cognitive Behaviour Therapy for Psychosis (CBTp) for the treatment of the ‘positive 
symptoms’ of schizophrenia, including distressing voices is recommended in international 
best practice guidelines.(Kreyenbuhk et al., 2010; National Collaborating Centre for Mental 
Health, 2014). CBTp has beneficial effects on voices with a small-medium effect size 
(Hedges g=0.44) (Van der Gaag, Valmaggia, & Smit, 2014). However, there are severe 
implementation challenges (van der Gaag, 2014) and access in the National Health Service 
in the UK is extremely limited with only 10% of patients who could benefit getting access to 
the therapy (Schizophrenia Commission, 2012). The barriers to increasing access include a 
lack of time for clinicians to deliver therapy (Haddock et al., 2014). Coping Strategy 
Enhancement (CSE, Tarrier, 1992) is a form of CBTp that has the potential to increase 
access due to its brevity. Furthermore, as a practical therapy focused upon behaviour 
change it may be deliverable by a wide range of clinicians including those with limited 
therapy experience.
The majority of hearers report one or more strategies used to ‘cope’ with voices (Farhall, 
Greenwood, & Jackson, 2007), suggesting most take actions of their own volition to cope 
with voices they appraise as a threat or challenge. Descriptively, these coping actions can 
be grouped (Tsai & Chen, 2006) into domains of: Doing something (Behavioural), e.g. such 
as a chore; Thinking differently (Cognitive), e.g. telling myself not to worry; and, Changing 
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sensations (Physiological), e.g. having a shower.  Most strategies are not specific to one’s 
culture, although there are some reported cross-cultural differences in emphasis (Loue & 
Sajatovic, 2008).  
Given the range of possible strategies for coping with voices, the hearer’s view of what 
works for them is a key perspective that may facilitate therapeutic engagement. This was the 
rationale of Tarrier and colleagues when they developed CSE. This approach was premised 
upon a functional analytic model in which triggers and reactions to psychotic experiences 
would influence the probability of their re-occurrence. The assumption was that patients had 
an existing repertoire of helpful coping strategies (i.e. strategies that targeted triggers and 
reactions), however the effectiveness of them was limited by their inconsistent and non-
strategic application.  
CSE was developed as a 10-session therapy for the broad range of psychotic symptoms and 
participants reported reductions in symptom severity within case studies (e.g. Tarrier, 
Harwood, Yusopoff, Beckett & Baker, 1990). Findings from a Randomised Controlled Trial 
(RCT) also showed improvements on measures of the number and severity of psychotic 
symptoms, but a more detailed analysis of separate symptoms suggested that this 
improvement was more evident for delusions than for voices (Tarrier et al, 1993). The 
authors suggest that this differential symptom response may have been attributable to 
issues of measurement, and they reported no evidence that voices responded less well 
when CSE was included as part of an integrated CBT package in a subsequent RCT (Tarrier 
et al, 2001). CSE has not subsequently been robustly evaluated as a stand-alone 
intervention for psychotic symptoms, leaving these issues unexplored. In the light of recent 
evidence suggesting that the effects of CBTp can be enhanced when focused upon a single 
symptom (Mehl, Werner & Lincoln, 2015), what might be the effects of CSE targeted 
exclusively upon voices? 
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We adapted CSE into a brief (4 session) intervention targeted specifically at distressing 
voices that could be delivered by a range of mental health practitioners as part of routine 
clinical practice. Voice-related distress was chosen as the primary outcome as it is the focus 
of the cognitive model of voices (Chadwick, Birchwood & Trower, 1996), is recommended as 
a therapeutic target by NICE (National Collaborating Centre for Mental Health, 2014), and is 
important to patients (Greenwood et al, 2010; Meddings & Perkins, 2002). This was an initial 
uncontrolled evaluation investigating the hypothesis that brief CSE would lead to a post-
treatment reduction in voice-related distress. 
Method 
Study design 
This was a service evaluation comparing pre-post outcomes in patients who had completed 
all four CSE sessions. Routine clinical data was collected at the baseline assessment (pre-
CSE) and at the post-CSE assessment by Research Assistants not involved in therapy 
delivery. As this was a service evaluation analysing data from routine clinical practice, no 
ethics approval was required (Department of Health, 2005). 
Patients were receiving a secondary care service within a single NHS Mental Health Trust in 
Sussex, UK. They were referred to the Voices Clinic, a specialist outpatient service for 
people distressed by hearing voices, irrespective of diagnosis. Eligibility criteria for the 
Voices Clinic required that patients scored at least 4 on the P3 item (‘hallucinatory behaviour 
- hallucinations occur frequently but not continuously, and the patient's thinking and 
behaviour are affected only to a minor extent’) of the Positive & Negative Symptom Scale 
(PANSS; Kay, Fiszbein & Opler, 1987) and at least 3 on one of the distress items 
(‘intensity of distress’ and ‘amount of distress’) of the Psychotic Symptoms Rating 
Scale – Auditory Hallucinations Scale (PSYRATS – AH; Haddock et al, 1999). 
Diagnosis was not an inclusion criterion. Between May 2014 and February 2017, 158 
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patients were offered CSE therapy and at the time of this report: 3 (2%) were waiting 
for therapy to begin, 5 (3%) were currently receiving therapy and 37 (23%) had 
dropped out. A total of 113 (72%) patients completed therapy, of whom 101 (64%) 
had also completed the post-therapy assessment. 
Intervention 
The CSE treatment consisted of a maximum of four hours (of up to one hour, offered 
approximately weekly) of individual therapy, guided by a therapy protocol and patient 
workbook (copies available from the first author on request). 
Session 1: 
A semi-structured interview (adapted from the Antecedent & Coping Interview, Tarrier et al, 
1990) was used to identify the antecedents to voice activity, and the patient’s emotional and 
behavioural responses to the voices. This stimulated a process of identifying coping 
strategies and evaluating their effectiveness.  
Session 2: 
An existing coping strategy was collaboratively selected and considered in detail. 
Discussions focussed upon how the strategy could be modified and used differently (more or 
less often). A plan was agreed to implement the strategy between sessions. 
Session 3: 
Implementation of the modified coping strategy was reviewed. Discussions focussed upon 
the enablers and barriers to implementation, and the effectiveness of the strategy. This 
strategy could be further modified to enhance effectiveness, or another strategy could be 
selected and modified. A plan was agreed to implement the strategy between sessions. 
Session 4: 
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Implementation of the modified coping strategy was reviewed, and any required 
modifications were agreed. Plans were discussed for continued implementation post-
therapy. Discussions explored any learning from therapy in relation to both self and voices, 
and the implications of this learning for living well with voices.  Any needs for further therapy 
were discussed. 
Therapy was provided by clinicians with varying experience of delivering therapy to people 
distressed by hearing voices. There were 26 therapists in total: 34 (34%) patients were seen 
by a clinical psychologist; 36 (36%) by a clinical/counselling psychology trainee; 28 (28%) by 
a mental health nurse or occupational therapist; and 3 (3%) by a CBT therapist. Therapists 
were taught to deliver CSE during a 90-minute training session facilitated the by the first 
author who also provided monthly supervision.  
All patients were receiving treatment-as-usual from their mental health teams during the 
course of the study. Treatment-as-usual consisted of regular outpatient appointments with a 
consultant psychiatrist, psychotropic medication and regular contact with clinical care team 
members. 
Assessment and measures 
Patients were assessed by a Research Assistant not involved in delivering therapy (in order 
to reduce risk of bias) at two time points: 1) Baseline - within four weeks before starting 
CSE; and 2) Post-therapy - within four weeks of finishing CSE. Baseline assessments 
included the collection of demographic information. Diagnostic information was verified by 
the treating psychiatrist. The study used the following clinical outcomes: 
Primary clinical outcome 
Psychotic Symptoms Rating Scale – Auditory Hallucinations (PSYRATS-AH) - an 11-item 
rating scale designed to measure the severity of different dimensions of voice hearing. Each 
item is rated 0-4, with higher scores indicating more difficulty. The four factor version of the 
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scale groups the items together as: distress (negative content, distress, and control; 
subscore range 0-20), frequency (frequency, duration, and disruption; subscore range 0-12), 
attribution (location and origin of voices; subscore range 0-8), and loudness (loudness item 
only; range 0-4) (Woodward et al., 2014). The 5-item distress scale was the primary 
outcome measure and is reported to be reliable (intraclass correlation coefficient = 093).  
The minimally clinically important difference (MCID) can be used as a reference point to help 
establish whether or not any pre-post treatment change is meaningful or not.  A reduction of 
3 points on the PSYRATS distress scale can be used as a primary indicator of change for 
patients. When interpreting the 95% confidence intervals around the pre-post treatment 
effect size, we are interested in seeing to what extent the true effect could be smaller or 
larger than the MCID threshold as well as whether it is non zero. 
Secondary clinical outcomes 
PSYRATS – AH Frequency subscale (described above).  
Choice of Outcome in CBT for Psychoses (CHOICE) – short-form – a 12-item form of the 
34-item self-report questionnaire developed with patients to assess goals for CBT for 
psychosis that are relevant to subjective recovery (Greenwood et al., 2010). Eleven items 
are related to the therapy to create a severity score and 1 item is a free text item where 
respondents can insert their personal goal.  All items are rated by patients on a 0-10 scale (0 
= worst, 10 = best). The short version was developed specifically for the IAPT-SMI initiative 
(Jolley et al, 2015), based on the highest loading items from the 34-item measure. Inter-
rater, internal, and test-retest reliability for the new measure are all good, as is criterion 
validity (Greenwood et al., 2012).  
DASS-21 – a 21 item self-report questionnaire measuring depression (7 items), anxiety (7 
items) and stress (7 items). Patients rate on a 0-3 scale how much a statement applies to 
them over the past week (0 = do not apply to me at all, 3 = applies to me very much/most of 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Page 8 of 22PDF For Review
the time). DASS-21 has excellent internal consistency and concurrent validity (Antony, 
Bieling, Cox, Enns, & Swinson, 1998) and adequate construct validity (Henry & Crawford, 
2005).  
Short Warwick Edinburgh Mental Well-being Scale (SWEMWS) – a 7 item self-report 
questionnaire measuring mental well-being. Patients rate on a 1-5 scale how much a 
statement (e.g. I’ve been feeling useful) applied to them over the past two weeks (1 = none 
of the time, 5 = all of the time). SWEMWS has adequate reliability (Stewart-brown, 2008) 
and external construct validity (Bartram, Sinclair, & Baldwin, 2013). 
Statistical analysis 
Patient characteristics and clinical outcomes were summarised using descriptive statistics: 
count (n), percentage (%), mean (m), standard deviation (sd) and range. For each clinical 
outcome measure with <75% missing items, the assumption of Missing at Random (MAR) 
was applied and multiple imputation using chained equations (MICE) was used (Eekhout et 
al, 2013). The imputation model consisted of all pre and post items for the measure and 
patient characteristics (diagnosis, age, gender, employment status, marital status, ethnic 
group and education) were included as auxiliary variables. Items were treated as 
continuous variables.  Ten imputations were used for each model. For each model, total pre 
and post scores were calculated and then compared using paired sample t-tests on n-1 
degrees of freedom as the primary analysis where the pre-post difference (mdiff) is the 
unstandardised effect size. The standardized effect size was calculated as Cohen’s 
d=tc[2(1-r)/n]1/2 where tc is the test statistic for correlated observations and r is the pre vs 
post score correlation 
(Dunlap et al., 1996). As a secondary analysis, a complete case analysis was carried out 
using paired sample t-tests after first being satisfied that the distribution of mdiff met the 
Normal criteria (Altman, 1991). If this was violated, bootstrapping was used to estimate the 
bias corrected accelerated (BCa) 95% confidence intervals.  Results from the complete 
analysis were then compared to the multiple imputation model results as a sensitivity 
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67 years; 69% unemployed; 60% single; and 97% currently prescribed psychotropic 
medication. With regard to ethnicity, 87% were White British or White Other which 
is representative of the geographical region.  
TABLE 1 ABOUT HERE 
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analysis. No attempts were made to correct for multiple testing because a primary outcome 
had been selected a priori and analyses of all other secondary outcomes were considered 
exploratory. All tests were significant at the 5% level. All analyses were carried out using 
STATA version 13.  
Results 
Data from a total of 101 patients who had attended 4 sessions of CSE and so received the 
full course of therapy were eligible for inclusion in this service evaluation. By individual 
outcome, the CHOICE goal rating had the highest level of missing paired data (n=37; 37%); 
this was due to the assessor not having the baseline goal information at the post-therapy 
assessment and the client not being able to recall their goal. Levels of missingness of pairs 
on the other total scores were as follows: SWEMWBS (n=21; 21%), CHOICE Severity (n=17; 
17%), Distress (n=21; 21%), Stress (n=17; 17%), Anxiety (n=16; 16%), Depression (n=16; 
16%) and Frequency (n=17; 17%). Across all 48 items and 101 patients, there were 4,848 
data points of which 5.4% were missing at baseline and 16.3% missing at post treatment. 
The demographic and clinical characteristics of the study sample can be found in Table 1. 
The sample was atypical as a significant majority (59%) of the patients had a non-psychotic 
disorder and the majority (52%) were female. With respect to other patient characteristics, 
the sample was similar to other studies of CBTp: mean age of 39 years ranging from 18 to 
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Data was imputed for 33 (12.5%) and 52 (6.6%) missing item responses at baseline and post 
therapy, respectively. Our primary analysis demonstrated improvement on the PSYRATS 
distress scale post-therapy when compared to the baseline (see Table 2). The mean change 
post-therapy was -1.7 (95% CI -2.80, -0.65) points on the subscale with the MCID of -3 
points sitting on the margin of the lower boundary of the 95% confidence interval. This was a 
small-medium effect size of d=0.39. The results also indicate promising levels of 
improvement on a number of the secondary outcomes with a large effect for CHOICE goal 
rating of 2.4 points (95% CI 1.62,3.22; d=0.74), and small effects sizes for CHOICE severity 
mean of 0.7 points (95% CI 036,0.94; d=0.34), depression of -1.3 (95% CI -2.24,-0.28; 
d=0.21), anxiety of -1.1 (95% CI -1.87,-0.42; d=0.22) and PSYRATS frequency of -0.8 points 
(95% CI -1.35,-0.23; d=0.31). These effects were all also statistically significant. The 
complete case analysis yielded very similar results to the primary analysis (see Table 2 for 
Cohen’s d, full results omitted). The two sets of results were compared as a sensitivity 
analysis and it was noted that: any differences were marginal, effect sizes and corresponding 
confidence intervals were of the same magnitude and all conclusions were consistent. 
TABLE 2 ABOUT HERE 
Discussion 
This study aimed to evaluate the impact of a single-symptom and brief form of CBTp upon 
the distress related to hearing voices. Most patients completed the full course of therapy, 
suggesting that it was acceptable to them and engaging. Statistically significant changes 
were found for the primary outcome of voice-related distress, albeit with a small-medium 
effect size, and the lower 95% confidence interval was inline with the minimum clinically 
important difference. These changes were accompanied by small effect sizes for reductions 
in secondary measures of emotional distress (anxiety and depression) and voice frequency. 
Other benefits were noted on a measure of subjective recovery (small effect size), with the 
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greatest benefit reported in relation to the patients’ personal goals (a large effect). These 
findings are encouraging in the context of the real-world clinical environment within which 
the therapy was delivered by a range of mental health practitioners. 
These findings add to the evolving literature suggesting that CBTp can delivered in a single 
symptom and mechanism-focused format (Van Der Gaag, Van Oosterhout, Daalman, 
Sommer, & Korrelboom, 2012) (Freeman et al., 2015). Whilst brief CSE seeks to adapt 
coping strategies, any increase in the effectiveness of these strategies may influence the 
client’s appraisals of self and voices, mechanisms that have been shown to be associated 
with emotional distress (Fannon et al, 2009). Given the key importance of distress reduction 
to patients (Greenwood et al., 2010; Meddings & Perkins, 2002) and commentators (Kuipers, 
Onwumere, & Peters, 2016), and evidence that it has not consistently been reduced by 
CBTp (Mawson, Cohen & Berry, 2010), the changes on the primary outcome were 
encouraging and suggest that researchers should seek to foreground the measurement of 
voice-related distress in future trials. This study also corroborated the suggestions from a 
recent review (Naeem et al., 2016) and meta-analysis (Hazell et al, 2016) that CBTp can be 
effective when offered over timeframes that are shorter than the 16 sessions recommended 
by NICE.  
Limitations 
Several words of caution are required in relation to the current study. Firstly, the evaluation 
was uncontrolled and the benefits may have occurred naturally over time. A future study of 
this adapted form of CSE would benefit from having a randomised controlled design to allow 
hypotheses of effectiveness to be tested directly. Secondly, the absence of follow-up data 
provides no indication of the extent to which benefits might have been sustained after 
therapy.  This is another question for future research. 
Clinical implications 
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CSE could be evaluated in a future randomised controlled trial as a standalone brief 
intervention with the intention of increasing access to CBTp for patients distressed by 
hearing voices. This would facilitate further evaluation of the relative merits of an intervention 
that could be made widely available (due to its brevity) but may only have modest effects. 
Alternatively, the modest and uncontrolled effect sizes within the current study can be 
interpreted as indicating that sustainable recovery may be more likely to occur if brief CSE 
were offered as an accessible and engaging ‘low intensity’ intervention offered by a range of 
mental health practitioners within a stepped care model (Waller et al, 2013).  Following brief 
CSE, if patients remain distressed, the next step could be informed by patient preference, 
and potentially include longer and more complex (‘high intensity’) therapies such as 
Mindfulness-based group therapy (Chadwick et al., 2016), Relating Therapy (Hayward, 
Overton, Dorey, & Denney, 2009), Avatar Therapy or Cognitive Therapy for Command 
Hallucinations (Birchwood et al, 2014), delivered by highly trained therapists.  
A final noteworthy finding concerns the large effect for the personal goal within the CHOICE 
measure. Many of the patients took this opportunity to articulate a change that had particular 
meaning to them, and for many patients (32%) the goal was not explicitly related to voices 
(e.g. to be more creative, to go out more, to feel better in myself). At a time when there 
continues to be debate about what should be measured to capture change in relation to 
distressing voices (e.g. distress, quality of life, impact on daily activities) (Thomas et al., 
2014), in addition to measuring distress as a primary outcome, we should ask each patient 
to express their views and ensure that this goal is foregrounded and regularly evaluated 
within therapy. 
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Table 1: Demographic and clinical characteristics of patients 
Characteristics Total n = 101 
39 (11, 18-67) 
48 (48%) 
52 (52%) 
88 (87%) 
 13 (13%) 
61 (60%) 
26 (26%) 
4 (4%) 
10 (10%) 
70 (69%) 
16 (16%) 
6 (6%) 
3 (3%) 
6 (6%) 
60 (59%) 
 41 (41%) 
Mean age in years (SD, range)  Gender
$ 
Males   
Females  
Ethnicity  
White British or white other 
Black and Minority Ethnic 
Marital status  
Single  
Married/cohabiting/long term 
relationship Widowed 
Separated/divorced  
Employment  
Unemployed 
Full time/part time paid employment 
Student  
Home maker  
Other  
Diagnosis 
Non-psychotic disorder  
Psychotic disorder  
Medication$ 
Yes   94 (97%) 
Note: Percentages are based on all available data for the variable; $=Data missing for 
characteristic: Gender (n=1); Medication (n=4). 
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